1. Skip to navigation
  2. Skip to content
  3. Skip to sidebar

Migraine Research

Leah Sarich | posted Wednesday, Jun 22nd, 2016

migraine

June is Migraine Awareness Month. Migraine is very common. It affects 12 percent of the population, 18 percent of women. It’s recognized as a major source of disability because migraines are debilitating headaches that can last a few hours up to a few days and are often accompanied by nausea, vomiting and sensitivity to light and sound.

Migraine specialist Dr. Werner Becker from the University of Calgary says there are three ways to tackle migraine. First, sufferers need to manage lifestyle factors like their stress, sleep and fatigue. Secondly, there’s treating the acute migraine with painkillers or triptans specifically designed for migraine headaches. Thirdly, there is prevention. Dr. Becker says there are a few ways they’re working to prevent migraines like injecting Botox into the heads of individuals who get chronic migraine or using certain heart medicines to reduce the frequency of migraines. But Dr. Becker says they’re not exactly sure how these strategies work.

But researchers are very excited about a whole new class of medications that are being investigated right now. They’re called CGRP antagonists. They’re drugs that target a specific molecule involved in the transmission of pain. Dr. Becker says because they’re so specific, they don’t involve other bodily systems which makes them have fewer side effects. They also seem to work very well to prevent migraine. So well, in fact, that in a small subgroup of patients these medicines stopped migraines from happening entirely.

That said, Dr. Becker says there will likely never be any one medication that works to prevent all migraines because these headaches are very complex and everyone experiences them differently. However, he says this new class of medication is extremely promising and he suspects they’ll be on the market in the next two to three years.

For more information on migraine headaches, visit this website. 

Comments

  • No comments have been left yet, get the conversation started!

Leave a Comment Below

Sign in to comment.

All fields are required.

Want to embed media into your comment? Just paste in a URL in a separate paragraph to the page where you would normally view the media (like on YouTube) and it will automatically be embedded into your comment.